This also correlated with a substantial increase (216%) of peripheral tumour antigen specific CD8+ T-cells expressing glucocorticoid-induced TNFR-related protein (GIRT), a marker of T-cell activation [166]. The gene discussed is CD8A; the disease is neoplasm.